Hemogenyx Pharmaceuticals PLC
LSE:HEMO
Shareholder Yield
Current shareholder yield for 
HEMO is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HEMO Price
Hemogenyx Pharmaceuticals PLC
| Average Annual Return | -24.4% |
| Standard Deviation of Annual Returns | 52.51% |
| Max Drawdown | -96% |
| Market Capitalization | 66.6m GBX |
| Shares Outstanding | 6 040 000 |
| Percentage of Shares Shorted |
N/A
|
HEMO Return Decomposition
Main factors of price return
Stock Splits
HEMO's latest stock split occurred on Dec 13, 2024
The company executed a 1-for-400 stock split, meaning that for every 400 shares held, investors received 1 new share.
Before the split, HEMO traded at 1.075 per share. Afterward, the share price was about 420.
The adjusted shares began trading on Dec 13, 2024. This was the only stock split in HEMO's history.
